Cardiovascular risk factors in patients with chronic kidney disease on hemodialysis
Keywords:
risk factors, cardiovascular diseases, renal insufficiency, chronic, renal dialysisAbstract
The occurrence of cardiovascular events is 10-30 times higher in hemodialysis patients than in the general population and it is the leading cause of mortality. Based on this problem a descriptive, cross-sectional and prospective study was conducted to describe the cardiovascular risk factors in patients with chronic kidney disease who initiated hemodialysis during the period from January to December 2012 in the Department of Nephrology in “Arnaldo Milián Castro” Universitary Provincial Hospital; population consisted of 63 patients with chronic kidney disease. It concluded with a predominance of male patients, the white skin and aged among 50 and 69 years; diabetic nephropathy was the most common cause of chronic kidney disease; blood hypertension, left ventricular hypertrophy and anemia were the cardiovascular risk factors most prevalent in the sample studied and most cardiovascular risk factors occurred more frequently in diabetic patients, except for smoking, which It was the only predominantly in vascular nephropathy.
Downloads
References
1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266.
2. Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006;333:1047-50.
3. Vlagopoulos PT, Sarnak MJ. Traditional and non-traditional cardiovascular risk factors in chronic kidney disease. Med Clin North Am. 2005;89:587-611.
4. Stevinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: No longer a simple plumbing problem. J Am Soc Nephrol. 2003;14:1927-39.
5. Atiés Sánchez Mirna C, Collado Nieto S. Factores de riesgo y complicaciones cardiovasculares en pacientes con enfermedad renal crónica en hemodiálisis: prevalencia, morbilidad y mortalidad. Rev Cubana Invest Biomed [Internet]. 2012 [citado 7 Jul 2013];31(2):[aprox. 7 p.]. Disponible en: http://bvs.sld.cu/revistas/ibi/vol31_2_12/ibi08212.htm
6. Berl T, Heinrich W. Kidney-heart interactions: epidemiology, pathogenesis and treatment. Clin J Am Soc Nephrol. 2006 Jan;1(1):8-18.
7. Fariña Peláez RA. Mortalidad en hemodiálisis, factores asociados [tesis]. Santa Clara: HAMC; 2009.
8. Hillege HL, van Gilst WH, van Veldhuisen DJ, Navis G, Grobbee DE, de Graeff PA, et al. CATS Randomized Trial. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J. 2003 Mar;24(5):412-20.
9. Factores de riesgo y complicaciones cardiovasculares en los pacientes en diálisis peritoneal. Rev Cub Med Int Emerg [Internet]. 2004 [citado 7 Jul 2013];3(4):[aprox. 7 p.]. Disponible en: http://bvs.sld.cu/revistas/mie/vol3_4_04/mie07404.pdf
10. Valdés S, Rojo Martínez G, Soriguer F. Evolución de la prevalencia de la diabetes tipo 2 en población adulta española. Med Clin Barc. 2007;129(18):716-7.
11. Informe de diálisis y Trasplante 2010. Sevilla: XL Congreso Nacional de la SEN; 14-17 Oct 2011.
12. Orth SR. Smoking and the kidney. J Am Soc Nephrol. 2002;132:1663-72.
13. Prevalencia de enfermedad cardiovascular en la uremia y relevancia de los factores de riesgo cardiovascular. Nefrología [Internet]. 2010 [citado 7 Jul 2013];30(3): [aprox. 5 p.]. Disponible en: http://www.revistanefrologia.com/modules.php?name=articulos&idarticulo=10443&idlangart=ES
14. Chanda J, Fenves AZF. Hypertension in patients with chronic kidney disease. Curr Hypertens Rep. 2009; 11:329-36.
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).